Abstract Title:

Antiangiogenic phytochemicals and medicinal herbs.

Abstract Source:

Phytother Res. 2011 Jan;25(1):1-10. PMID: 20564543

Abstract Author(s):

Soo-Jin Jeong, Wonil Koh, Eun-Ok Lee, Hyo-Jung Lee, Hyo-Jeong Lee, Hyunsu Bae, Junxuan Lü, Sung-Hoon Kim

Article Affiliation:

College of Oriental Medicine, Kyung Hee University, Seoul 130-701, Republic of Korea.

Abstract:

Medicinal herbs and their phytochemicals are potential novel leads for developing antiangiogenic drugs. This review aims to assess the current status of research with medicinal herbs and their phytochemicals for the development of antiangiogenic agents for cancer and other angiogenesis-related diseases including inflammation, diabetic retinopathy, endometriosis and obesity. Most studies reviewed have focused on vascular endothelial growth factor (VEGF)/vascular endothelial growth factor receptor 2 (VEGFR-2) signaling for endothelial response processes and have led to the identification of many potential antiangiogenic agents. Since human clinical trials with antiangiogenic modalities targeting VEGF/VEGFR-2 signaling have shown limited efficacy and occasional toxic side effects, screening strategies for herbal phytochemicals based on other signaling pathways important for cancer-endothelial and stromal crosstalks should be emphasized in the future. Copyright© 2010 John Wiley&Sons, Ltd.

Study Type : Review

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.